John Nicholson
2015
In 2015, John Nicholson earned a total compensation of $2M as Senior Vice President and Chief Financial Officer at Nektar Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $267,500 |
---|---|
Option Awards | $319,528 |
Salary | $563,100 |
Stock Awards | $808,594 |
Other | $12,661 |
Total | $1,971,383 |
Nicholson received $808.6K in stock awards, accounting for 41% of the total pay in 2015.
Nicholson also received $267.5K in non-equity incentive plan, $319.5K in option awards, $563.1K in salary and $12.7K in other compensation.
Rankings
In 2015, John Nicholson's compensation ranked 4,780th out of 13,638 executives tracked by ExecPay. In other words, Nicholson earned more than 65.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,780 out of 13,638 | 65th |
Division Manufacturing | 1,757 out of 5,190 | 66th |
Major group Chemicals And Allied Products | 627 out of 1,854 | 66th |
Industry group Drugs | 497 out of 1,528 | 68th |
Industry Pharmaceutical Preparations | 395 out of 1,182 | 67th |
Source: SEC filing on April 29, 2016.
Nicholson's colleagues
We found five more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2015.
2015
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2015
Gil Labrucherie
Nektar Therapeutics
General Counsel
2015
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Manufacturing Operations
2015
Ivan Gergel
Nektar Therapeutics
Chief Medical Officer
2015
Stephen Doberstein
Nektar Therapeutics